Last reviewed · How we verify
Chronic Myeloid Leukemia (CML)
Approved treatments
- Valchlor · Recordati
Valchlor works by attaching an alkyl group to the DNA of cancer cells, interfering with their ability to replicate and ultimately leading to cell death. - Synribo · Teva Pharms Intl
- Vindesin · The Lymphoma Academic Research Organisation
- Homoharringtonine · ChemGenex Pharmaceuticals
- Cyclophosphamid · Zhejiang University
- Eldisine
- Uramustin
- Cytoxan (Lyophilized) · Baxter
Cyclophosphamide cross-links tumor cell DNA and interferes with malignant cell growth through active alkylating metabolites. - Cytoxan (Lyophilized) · Baxter
Cytoxan works by interfering with the DNA replication process in rapidly dividing cancer cells. - Hydroxycarbamide · University of Birmingham
- Siklos · Theravia
- Xromi · Nova Laboratories Limited
- Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- Omacetaxine · University of Illinois at Chicago
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape: